Danober_1993_Eur.J.Pharmacol_234_263

Reference

Title : Effects of cholinergic drugs on genetic absence seizures in rats - Danober_1993_Eur.J.Pharmacol_234_263
Author(s) : Danober L , Depaulis A , Marescaux C , Vergnes M
Ref : European Journal of Pharmacology , 234 :263 , 1993
Abstract :

Wistar rats of a selected strain show spontaneous generalized non-convulsive seizures with bilateral synchronous spike-wave discharges on the cortical electroencephalograph (EEG). The 7 to 9 c/s spike-wave discharges occur predominantly in waking states of inactivity. The effects of cholinergic drugs on the cumulated duration of spike-wave discharges were investigated in this rat model of absence epilepsy. I.p. injections of drugs which potentiate cholinergic neurotransmission, namely the acetylcholinesterase inhibitor, physostigmine (0.1-0.5 mg/kg), the muscarinic receptor agonists, oxotremorine (0.25-1 mg/kg) and pilocarpine (0.125-2 mg/kg), and the nicotinic receptor agonist, nicotine (0.062-2 mg/kg), suppressed discharges in a dose-dependent manner and induced an arousal-like cortical EEG. The muscarinic receptor antagonist, scopolamine, increased the spike-wave discharges at doses below 0.05 mg/kg; at higher doses (0.05-1 mg/kg) it decreased discharges and induced a sleep-like EEG. The nicotinic receptor antagonist, mecamylamine (0.5-6 mg/kg), had no effect on spike-wave discharges or the EEG. These results suggest that cholinergic activity accounts for the preferential occurrence of absence seizures in states of reduced arousal.

PubMedSearch : Danober_1993_Eur.J.Pharmacol_234_263
PubMedID: 8387012

Related information

Citations formats

Danober L, Depaulis A, Marescaux C, Vergnes M (1993)
Effects of cholinergic drugs on genetic absence seizures in rats
European Journal of Pharmacology 234 :263

Danober L, Depaulis A, Marescaux C, Vergnes M (1993)
European Journal of Pharmacology 234 :263